04a228cd404455b9…

{
  "id": "NCT00106899",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). This information will aid future clinical trials by providing a standard assessment tool to measure the effects of treatments being studied.",
    "completionDate": "2011-06",
    "conditions": [
      "Alzheimer's Disease"
    ],
    "enrollmentCount": 818,
    "enrollmentType": "ACTUAL",
    "nctId": "NCT00106899",
    "phase": null,
    "sponsorId": "alzheimer-s-disease-cooperative-study-adcs",
    "startDate": "2005-07",
    "status": "COMPLETED",
    "studyType": "OBSERVATIONAL",
    "title": "Alzheimer's Disease Neuroimaging Initiative",
    "url": "https://clinicaltrials.gov/study/NCT00106899"
  }
}